NCT00060268View on ClinicalTrials.gov

Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal Tumors

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

January 31, 1997

Primary Completion Date

September 30, 2003

Study Completion Date

June 30, 2004

Conditions
Esophageal Cancer
Interventions
DRUG

HPPH

iv

Trial Locations (1)

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER

NCT00060268 - Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal Tumors | Biotech Hunter | Biotech Hunter